Fluid and Neurophysiological Biomarkers for the Early Diagnosis of Progression of RRMS to SPMS
In this podcast, Dr Coyle discusses the clinical course of progression from relapsing-remitting forms of multiple sclerosis (MS) to secondary progressive MS, as well as the current state of evidence on the role of fluid and neurophysiological biomarkers in the early diagnosis of progression of relapsing-remitting MS to secondary progressive MS. For more podcasts like this, visit www.consultant360.com/neurology.